000			01915 a2200553 4500
005			20250517150725.0
264		0	_c20170821
008			201708s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2017.04.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Xi
245	0	0	_aTherapeutic effects of Argyrin F in pancreatic adenocarcinoma. _h[electronic resource]
260			_bCancer letters _c07 2017
300			_a20-28 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma, Pancreatic Ductal _xblood supply
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Movement _xdrug effects
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21 _xmetabolism
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xmetabolism
650	0	4	_aCyclooxygenase 2 _xmetabolism
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aG1 Phase Cell Cycle Checkpoints _xdrug effects
650	0	4	_aHumans
650	0	4	_aMice, Transgenic
650	0	4	_aNeoplasm Invasiveness
650	0	4	_aNeovascularization, Pathologic
650	0	4	_aPancreatic Neoplasms _xblood supply
650	0	4	_aPeptides, Cyclic _xpharmacology
650	0	4	_aProtein Stability
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTumor Burden _xdrug effects
700	1		_aBui, Khac Cuong
700	1		_aBarat, Samarpita
700	1		_aThi Nguyen, Mai Ly
700	1		_aBozko, Przemyslaw
700	1		_aSipos, Bence
700	1		_aKalesse, Markus
700	1		_aMalek, Nisar P
700	1		_aPlentz, Ruben R
773	0		_tCancer letters _gvol. 399 _gp. 20-28
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2017.04.003 _zAvailable from publisher's website
999			_c27079887 _d27079887